146 related articles for article (PubMed ID: 35263708)
1. Discovery of (S)-N-(3-isopropylphenyl)-2-(5-phenylthiazol-2-yl)pyrrolidine-1-carboxamide as potent and brain-penetrant TRPV1 antagonist.
Qiao Y; Zhang Y; Qiao Z; He W; Chen Y; Song D; Wang G; Guo N; Shao L; Tian Z; Wang Q; Yan L; Qian H
Eur J Med Chem; 2022 Apr; 233():114191. PubMed ID: 35263708
[TBL] [Abstract][Full Text] [Related]
2. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H
Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049
[TBL] [Abstract][Full Text] [Related]
3. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
[TBL] [Abstract][Full Text] [Related]
4. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonist.
Kitagawa Y; Miyai A; Usui K; Hamada Y; Deai K; Wada M; Koga Y; Sakata M; Hayashi M; Tominaga M; Matsushita M
J Pharmacol Exp Ther; 2012 Aug; 342(2):520-8. PubMed ID: 22588258
[TBL] [Abstract][Full Text] [Related]
6. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.
Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S
J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669
[TBL] [Abstract][Full Text] [Related]
7. Novel dual-target μ‑opioid and TRPV1 ligands as potential pharmacotherapeutics for pain management.
Gao M; Zhang Y; Wang B; Guo N; Shao L; Zhai W; Jiang L; Wang Q; Qian H; Yan L
Bioorg Chem; 2023 Feb; 131():106335. PubMed ID: 36603243
[TBL] [Abstract][Full Text] [Related]
8. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.
Rami HK; Thompson M; Stemp G; Fell S; Jerman JC; Stevens AJ; Smart D; Sargent B; Sanderson D; Randall AD; Gunthorpe MJ; Davis JB
Bioorg Med Chem Lett; 2006 Jun; 16(12):3287-91. PubMed ID: 16580202
[TBL] [Abstract][Full Text] [Related]
9. 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands.
Kim C; Ann J; Lee S; Kim E; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2018 Aug; 26(15):4509-4517. PubMed ID: 30078610
[TBL] [Abstract][Full Text] [Related]
10. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
[TBL] [Abstract][Full Text] [Related]
11. Phenylquinoline transient receptor potential vanilloid 1 antagonists for the treatment of pain: Discovery of 1-(2-phenylquinoline-4-carbonyl)-N-(4-(trifluoromethyl)phenyl)pyrrolidine-3-carboxamide.
Liao C; Liu Y; Liu C; Zhou J; Li H; Wang N; Li J; Liu T; Ghaleb H; Huang W; Qian H
Bioorg Med Chem; 2018 Feb; 26(4):845-854. PubMed ID: 29317149
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists.
Huang G; Jung A; Li LX; Do N; Jung S; Jeon Y; Zuo D; Thanh La M; Van Manh N; Blumberg PM; Yoon H; Lee Y; Ann J; Lee J
Bioorg Med Chem Lett; 2024 Jul; 106():129735. PubMed ID: 38588785
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists.
Li J; Nie C; Qiao Y; Hu J; Li Q; Wang Q; Pu X; Yan L; Qian H
Eur J Med Chem; 2019 Sep; 178():433-445. PubMed ID: 31202991
[TBL] [Abstract][Full Text] [Related]
14. Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1.
Liu Y; Liao C; Zhou J; Liu C; Li Q; Jiang Y; Qian H
Bioorg Med Chem; 2018 Aug; 26(15):4567-4573. PubMed ID: 30093345
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects
Liang Q; Qiao Z; Zhou Q; Xue D; Wang K; Shao L
J Med Chem; 2022 Sep; 65(17):11658-11678. PubMed ID: 36008373
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
18. A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds.
Caballero J
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2169-2178. PubMed ID: 35975286
[TBL] [Abstract][Full Text] [Related]
19. Discovery of N-(1-(2-hydroxyethyl)quinolin-2-one)-N'-(1-phenyl-1H-pyrazol-5-yl)methyl) urea as Mode-Selective TRPV1 antagonist.
Zuo D; Hong M; Jung A; Lee S; Do N; Jung S; Jeon Y; Won Jeong J; Huang G; Li LX; Blumberg PM; Yoon H; Lee Y; Ann J; Lee J
Bioorg Med Chem Lett; 2024 Mar; 101():129656. PubMed ID: 38355061
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD).
Jin F; Wen Y; Lin G; Yu S; Wang C; Ye W; Zhang J
Bioorg Med Chem; 2023 Jul; 90():117379. PubMed ID: 37336082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
